vs
Side-by-side financial comparison of SELECT MEDICAL HOLDINGS CORP (SEM) and VinFast Auto Ltd. (VFS). Click either name above to swap in a different company.
SELECT MEDICAL HOLDINGS CORP is the larger business by last-quarter revenue ($1.4B vs $718.6M, roughly 1.9× VinFast Auto Ltd.). SELECT MEDICAL HOLDINGS CORP runs the higher net margin — 1.4% vs -2.8%, a 4.2% gap on every dollar of revenue.
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
VinFast Auto Ltd. is a Vietnamese multinational automotive company founded by Vingroup, one of the largest private conglomerates in Vietnam that was founded by Phạm Nhật Vượng.
SEM vs VFS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $718.6M |
| Net Profit | $20.2M | $-20.0M |
| Gross Margin | — | — |
| Operating Margin | 4.6% | -96.1% |
| Net Margin | 1.4% | -2.8% |
| Revenue YoY | 6.4% | — |
| Net Profit YoY | 225.7% | — |
| EPS (diluted) | $0.17 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | $718.6M | ||
| Q2 25 | $1.3B | $663.0M | ||
| Q1 25 | $1.4B | $656.5M | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | $511.6M | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.3B | $302.6M |
| Q4 25 | $20.2M | — | ||
| Q3 25 | $28.8M | $-20.0M | ||
| Q2 25 | $40.6M | $-51.8M | ||
| Q1 25 | $56.7M | $-26.1M | ||
| Q4 24 | $-16.1M | — | ||
| Q3 24 | $55.6M | $-10.4M | ||
| Q2 24 | $77.6M | — | ||
| Q1 24 | $96.9M | $-618.3M |
| Q4 25 | 4.6% | — | ||
| Q3 25 | 5.4% | -96.1% | ||
| Q2 25 | 6.5% | -79.0% | ||
| Q1 25 | 8.3% | -74.0% | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 4.3% | -65.9% | ||
| Q2 24 | 5.8% | — | ||
| Q1 24 | 9.0% | -139.4% |
| Q4 25 | 1.4% | — | ||
| Q3 25 | 2.1% | -2.8% | ||
| Q2 25 | 3.0% | -7.8% | ||
| Q1 25 | 4.2% | -4.0% | ||
| Q4 24 | -1.2% | — | ||
| Q3 24 | 4.4% | -2.0% | ||
| Q2 24 | 6.1% | — | ||
| Q1 24 | 7.3% | -204.3% |
| Q4 25 | $0.17 | — | ||
| Q3 25 | $0.23 | — | ||
| Q2 25 | $0.32 | — | ||
| Q1 25 | $0.44 | — | ||
| Q4 24 | $-0.12 | — | ||
| Q3 24 | $0.43 | — | ||
| Q2 24 | $0.60 | — | ||
| Q1 24 | $0.75 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $26.5M | $8.8M |
| Total DebtLower is stronger | $1.8B | — |
| Stockholders' EquityBook value | $1.7B | — |
| Total Assets | $5.9B | $183.2M |
| Debt / EquityLower = less leverage | 1.06× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.5M | — | ||
| Q3 25 | $60.1M | $8.8M | ||
| Q2 25 | $52.3M | $650.0M | ||
| Q1 25 | $53.2M | $2.4M | ||
| Q4 24 | $59.7M | — | ||
| Q3 24 | $191.5M | $1.9M | ||
| Q2 24 | $111.2M | — | ||
| Q1 24 | $92.6M | $3.0M |
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.8B | — | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $3.1B | — | ||
| Q2 24 | $3.6B | — | ||
| Q1 24 | $3.8B | — |
| Q4 25 | $1.7B | — | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $1.7B | $-7.2B | ||
| Q1 25 | $1.7B | — | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $1.4B | — |
| Q4 25 | $5.9B | — | ||
| Q3 25 | $5.7B | $183.2M | ||
| Q2 25 | $5.7B | $7.2B | ||
| Q1 25 | $5.7B | $158.2M | ||
| Q4 24 | $5.6B | — | ||
| Q3 24 | $8.0B | $151.8M | ||
| Q2 24 | $7.9B | — | ||
| Q1 24 | $7.9B | $145.6M |
| Q4 25 | 1.06× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 1.10× | — | ||
| Q1 25 | 1.03× | — | ||
| Q4 24 | 1.01× | — | ||
| Q3 24 | 1.62× | — | ||
| Q2 24 | 2.54× | — | ||
| Q1 24 | 2.75× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $64.3M | — |
| Free Cash FlowOCF − Capex | $5.2M | — |
| FCF MarginFCF / Revenue | 0.4% | — |
| Capex IntensityCapex / Revenue | 4.2% | — |
| Cash ConversionOCF / Net Profit | 3.19× | — |
| TTM Free Cash FlowTrailing 4 quarters | $117.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $64.3M | — | ||
| Q3 25 | $175.3M | — | ||
| Q2 25 | $110.3M | — | ||
| Q1 25 | $-3.5M | — | ||
| Q4 24 | $125.4M | — | ||
| Q3 24 | $181.0M | — | ||
| Q2 24 | $278.2M | — | ||
| Q1 24 | $-66.7M | — |
| Q4 25 | $5.2M | — | ||
| Q3 25 | $122.2M | — | ||
| Q2 25 | $45.6M | — | ||
| Q1 25 | $-55.8M | — | ||
| Q4 24 | $62.0M | — | ||
| Q3 24 | $130.3M | — | ||
| Q2 24 | $222.6M | — | ||
| Q1 24 | $-119.2M | — |
| Q4 25 | 0.4% | — | ||
| Q3 25 | 9.0% | — | ||
| Q2 25 | 3.4% | — | ||
| Q1 25 | -4.1% | — | ||
| Q4 24 | 4.7% | — | ||
| Q3 24 | 10.2% | — | ||
| Q2 24 | 17.4% | — | ||
| Q1 24 | -9.0% | — |
| Q4 25 | 4.2% | — | ||
| Q3 25 | 3.9% | — | ||
| Q2 25 | 4.8% | — | ||
| Q1 25 | 3.9% | — | ||
| Q4 24 | 4.8% | — | ||
| Q3 24 | 4.0% | — | ||
| Q2 24 | 4.3% | — | ||
| Q1 24 | 4.0% | — |
| Q4 25 | 3.19× | — | ||
| Q3 25 | 6.09× | — | ||
| Q2 25 | 2.72× | — | ||
| Q1 25 | -0.06× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.25× | — | ||
| Q2 24 | 3.59× | — | ||
| Q1 24 | -0.69× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
VFS
| Sales of vehicles | $662.9M | 92% |
| Sales of spare parts and components | $41.3M | 6% |
| Revenue from leasing activities | $12.3M | 2% |
| Finance income | $2.4M | 0% |
| Rendering of services | $1.2M | 0% |
